Q2 2024 Holdings
Filed 2024-08-14 | 128 holdings | $981.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $61.3M | 2,254,797 | 6.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $52.6M | 4,847,399 | 5.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $49.7M | 4,218,829 | 5.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $44.0M | 1,287,107 | 4.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $33.4M | 1,330,879 | 3.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $28.7M | 450,000 | 2.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $28.1M | 2,500,000 | 2.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $24.4M | 27,000 | 2.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $24.4M | 1,500,000 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $22.7M | 300,000 | 2.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $21.4M | 700,000 | 2.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $20.5M | 300,000 | 2.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $18.3M | 2,750,000 | 1.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $18.1M | 1,392,925 | 1.8% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $17.3M | 1,230,000 | 1.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $17.1M | 316,500 | 1.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $16.1M | 750,000 | 1.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $16.1M | 921,138 | 1.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $15.9M | 2,779,500 | 1.6% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $15.4M | 400,000 | 1.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $14.9M | 140,000 | 1.5% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $14.8M | 4,476,741 | 1.5% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $14.2M | 115,019 | 1.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $13.7M | 405,600 | 1.4% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $12.9M | 747,616 | 1.3% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $12.2M | 2,153,307 | 1.2% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $12.0M | 1,619,412 | 1.2% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.7M | 150,000 | 1.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $11.7M | 625,309 | 1.2% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $11.0M | 3,751,864 | 1.1% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $10.9M | 2,330,000 | 1.1% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $9.9M | 8,216,960 | 1.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $9.8M | 1,000,000 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.5M | 7,791,936 | 1.0% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $9.4M | 572,697 | 1.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $9.4M | 1,100,000 | 1.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $8.7M | 720,000 | 0.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $8.5M | 281,200 | 0.9% |
| Elevation Oncology Inc | COM | 28623U101 | $8.3M | 3,060,000 | 0.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $8.1M | 35,000 | 0.8% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $7.5M | 1,603,200 | 0.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.2M | 805,440 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.2M | 3,100,000 | 0.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.1M | 150,000 | 0.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.9M | 264,692 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.7M | 100,000 | 0.7% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $6.5M | 1,850,000 | 0.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.4M | 120,000 | 0.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $6.3M | 270,000 | 0.6% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $6.1M | 623,332 | 0.6% |